Calculate CPP from MAP and ICP with tiered management guidance, ICP scenario modeling, pediatric targets, and cerebral autoregulation reference.
Cerebral perfusion pressure (CPP) is the net pressure gradient driving blood flow to the brain, calculated as the difference between mean arterial pressure (MAP) and intracranial pressure (ICP): CPP = MAP − ICP. It is the single most important hemodynamic parameter in the management of traumatic brain injury (TBI) and other neurological emergencies.
The Brain Trauma Foundation (BTF) 4th Edition Guidelines (2016) recommend maintaining CPP between 60-70 mmHg in adults with severe TBI. CPP below 50 mmHg is associated with cerebral ischemia and poor outcomes, while CPP above 70 mmHg achieved through aggressive vasopressor use increases the risk of acute respiratory distress syndrome (ARDS) without improving neurological outcomes.
This calculator computes CPP from systolic/diastolic blood pressure (or direct MAP), models CPP across a range of ICP values, provides tiered ICP management protocols, age-specific pediatric targets, estimated cerebral blood flow, and cerebral autoregulation reference data for informed clinical decision-making. Check the example with realistic values before reporting.
CPP is the fundamental parameter for brain herniation prevention in neurocritical care. This calculator provides real-time CPP computation, ICP scenario modeling, age-appropriate targets, and evidence-based management tier references. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain. Use this clarification to avoid ambiguous interpretation. Align this note with review checkpoints.
CPP = MAP − ICP MAP = DBP + (SBP − DBP) / 3 Where: - CPP = Cerebral Perfusion Pressure (mmHg) - MAP = Mean Arterial Pressure (mmHg) - ICP = Intracranial Pressure (mmHg) - Normal CBF ≈ 50 mL/100g/min maintained by autoregulation across CPP 50-150 mmHg
Result: MAP = 85 + (130−85)/3 = 100 mmHg. CPP = 100 − 25 = 75 mmHg.
Despite elevated ICP of 25 mmHg (treatment threshold), the MAP of 100 mmHg maintains adequate CPP of 75 mmHg. However, ICP treatment should still be initiated at ≥20-22 mmHg per BTF guidelines to prevent further elevation.
The skull is a rigid container with fixed volume. Its contents — brain parenchyma (~80%), cerebrospinal fluid (~10%), and blood (~10%) — must remain in equilibrium. An increase in one component (e.g., edema, hemorrhage, hydrocephalus) must be compensated by decreased volume of another, or ICP rises. Once compensatory mechanisms are exhausted (CSF displacement, venous compression), small additional volume increases cause exponential ICP rises — the steep portion of the intracranial compliance curve.
Two philosophical approaches have evolved in TBI management: CPP-guided therapy (Rosner protocol) emphasizes maintaining CPP > 70 mmHg with vasopressors, while ICP-guided therapy (Lund protocol) focuses on reducing ICP through capillary filtration pressure reduction. The BEST:TRIP trial (2012) found no difference between ICP-monitored and imaging-clinical management, but this has been interpreted as evidence for better integration of multiple monitoring modalities rather than abandoning ICP monitoring.
The PRx correlates slow fluctuations in ICP with MAP. When autoregulation is intact, ICP decreases when MAP rises (negative PRx); when impaired, ICP passively follows MAP (positive PRx > 0.25). The "optimal CPP" (CPPopt) — the CPP at which PRx is most negative — can be identified at the bedside. Patients managed near their CPPopt have been shown to have improved outcomes in observational studies. Prospective trials (COGiTATE) are evaluating CPPopt-guided therapy.
Normal adult CPP is 60-80 mmHg with a normal ICP of 5-15 mmHg. The BTF recommends targeting CPP 60-70 mmHg in severe TBI. Values below 50 mmHg are associated with cerebral ischemia, while values above 70 mmHg achieved with vasopressors may cause pulmonary complications. The optimal CPP varies by individual and can be guided by autoregulation monitoring (PRx index).
The landmark Robertson trial (1999) showed that aggressively targeting CPP > 70 mmHg with vasopressors led to a 5-fold increase in ARDS without improving neurological outcomes. The current approach targets a "CPP optimization" strategy: maintain CPP ≥ 60 mmHg primarily by reducing ICP, with judicious vasopressor use. Modern multimodality monitoring (brain tissue oxygen, microdialysis) can guide individualized targets.
BTF 4th Edition guidelines recommend treatment of ICP > 22 mmHg (updated from the previous 20 mmHg threshold). This is based on evidence showing that sustained ICP > 22 mmHg is associated with increased mortality. However, treatment should also consider the duration of elevation, waveform morphology, and response trends rather than a single threshold.
Children have lower baseline blood pressure, so age-appropriate CPP targets are lower: > 30 mmHg in neonates, > 40 mmHg in infants, > 50 mmHg in children 1-10 years, and > 55-60 mmHg in adolescents. Pediatric TBI guidelines are less evidence-based than adult guidelines and recommendations are largely extrapolated from adult data and expert consensus.
Cerebral autoregulation is the brain ability to maintain constant cerebral blood flow (CBF) despite changes in CPP, normally effective across CPP 50-150 mmHg. Arterioles dilate when CPP falls and constrict when CPP rises. In TBI, autoregulation is often impaired — CBF becomes "pressure-passive" and tracks changes in CPP directly. The pressure reactivity index (PRx) can assess autoregulation status at the bedside.
Head-of-bed elevation to 30° is a standard ICP management measure. It reduces ICP by promoting venous drainage via the jugular veins. However, head elevation also slightly reduces MAP (by reducing hydrostatic pressure at the level of the brain). The net effect is usually beneficial: ICP decreases more than MAP, resulting in improved CPP. The transducer should be zeroed at the level of the tragus (external auditory meatus).